SK44197A3 - Peptides modulating the activity of anti-idiotypic t-cells and pharmaceutical compositions containing them, usable in diagnostics and therapy of diabetes mellitus of i.type - Google Patents

Peptides modulating the activity of anti-idiotypic t-cells and pharmaceutical compositions containing them, usable in diagnostics and therapy of diabetes mellitus of i.type Download PDF

Info

Publication number
SK44197A3
SK44197A3 SK441-97A SK44197A SK44197A3 SK 44197 A3 SK44197 A3 SK 44197A3 SK 44197 A SK44197 A SK 44197A SK 44197 A3 SK44197 A3 SK 44197A3
Authority
SK
Slovakia
Prior art keywords
sequence
cells
peptide
cell
idiotypic
Prior art date
Application number
SK441-97A
Other languages
English (en)
Slovak (sk)
Inventor
Irun R Cohen
Dana Elias
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of SK44197A3 publication Critical patent/SK44197A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK441-97A 1994-10-07 1995-10-10 Peptides modulating the activity of anti-idiotypic t-cells and pharmaceutical compositions containing them, usable in diagnostics and therapy of diabetes mellitus of i.type SK44197A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11119694A IL111196A0 (en) 1994-10-07 1994-10-07 Peptides and pharmaceutical compositions comprising them
PCT/US1995/012686 WO1996011214A1 (en) 1994-10-07 1995-10-10 Peptides and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
SK44197A3 true SK44197A3 (en) 1997-11-05

Family

ID=11066614

Family Applications (1)

Application Number Title Priority Date Filing Date
SK441-97A SK44197A3 (en) 1994-10-07 1995-10-10 Peptides modulating the activity of anti-idiotypic t-cells and pharmaceutical compositions containing them, usable in diagnostics and therapy of diabetes mellitus of i.type

Country Status (15)

Country Link
EP (1) EP0783524B1 (cs)
JP (1) JPH10507345A (cs)
KR (1) KR100381711B1 (cs)
AT (1) ATE289611T1 (cs)
AU (1) AU708301B2 (cs)
CA (1) CA2201935A1 (cs)
CZ (1) CZ103197A3 (cs)
DE (1) DE69534024T2 (cs)
FI (1) FI971427A7 (cs)
HU (1) HUT77484A (cs)
IL (1) IL111196A0 (cs)
NO (1) NO971517L (cs)
PL (1) PL319831A1 (cs)
SK (1) SK44197A3 (cs)
WO (1) WO1996011214A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716963B1 (en) 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US8143380B2 (en) 2004-07-08 2012-03-27 Amgen Inc. Therapeutic peptides
WO2006036834A2 (en) 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
EP3122768A2 (en) * 2014-03-27 2017-02-01 Yeda Research and Development Co. Ltd. T-cell receptor cdr3 peptides and antibodies
PL3560954T3 (pl) 2014-04-03 2021-12-13 Igm Biosciences, Inc. Zmodyfikowany łańcuch J
EP3355913B1 (en) 2015-09-30 2024-10-30 IGM Biosciences, Inc. Binding molecules with modified j-chain
EP3356401B1 (en) 2015-09-30 2020-06-24 IGM Biosciences, Inc. Binding molecules with modified j-chain
CN120699093B (zh) * 2025-06-26 2026-04-14 华中农业大学 一种蛋黄源降血糖肽及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof

Also Published As

Publication number Publication date
DE69534024D1 (de) 2005-03-31
EP0783524B1 (en) 2005-02-23
CA2201935A1 (en) 1996-04-18
CZ103197A3 (en) 1997-09-17
KR970706306A (ko) 1997-11-03
FI971427A0 (fi) 1997-04-04
EP0783524A4 (en) 2000-05-17
NO971517L (no) 1997-05-22
FI971427L (fi) 1997-05-26
AU3946295A (en) 1996-05-02
NO971517D0 (no) 1997-04-03
PL319831A1 (en) 1997-09-01
AU708301B2 (en) 1999-07-29
JPH10507345A (ja) 1998-07-21
DE69534024T2 (de) 2006-01-12
IL111196A0 (en) 1994-12-29
ATE289611T1 (de) 2005-03-15
EP0783524A1 (en) 1997-07-16
FI971427A7 (fi) 1997-05-26
HUT77484A (hu) 1998-05-28
KR100381711B1 (ko) 2003-07-16
WO1996011214A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
French et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
US7704970B2 (en) DNA vaccination for treatment of autoimmune disease
AU2002341266B2 (en) Use of HMGB1 for the activation of dendritic cells
US5939400A (en) DNA vaccination for induction of suppressive T cell response
PT1249490E (pt) Activação de células t citotóxicas in vitro
AU651350B2 (en) Multiple sclerosis T-cell receptor
US6096314A (en) Peptides and pharmaceutical compositions comprising them
SK44197A3 (en) Peptides modulating the activity of anti-idiotypic t-cells and pharmaceutical compositions containing them, usable in diagnostics and therapy of diabetes mellitus of i.type
CA2110055C (en) T cell receptor peptides as therapeutics for immune-related disease
US6464978B1 (en) Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
Raju et al. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice
CN101316610A (zh) T细胞受体恒定区的免疫原性片段及其衍生的肽
CA2363269C (en) Dna vaccination for treatment of autoimmune disease
JP2010207226A (ja) Ｔ細胞レセプターｃｄｒ３配列および検出のための方法
WO2004098645A1 (en) Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
KR20030086983A (ko) 티 세포 리셉터 브이 베타 - 디 베타 - 제이 베타 서열과그것을 검출하는 방법
KR20050016491A (ko) 티세포 수용체 씨디알3 서열 및 검출방법
Sarukhan et al. An Analysis of T cell receptor diversity in the NOD mouse: What can it tell us about the autoimmune process?
Sercarz Encephalitogenic Epitopes of Myelin
BG63183B2 (bg) Анти-идиотипна ваксина срещу заболявания в резултат от патогенни отговори на специфични т-клетъчни популации
BG62348B2 (bg) Ваксиниране чрез специфични т-клетъчни популации срещу заболявания в резултат на патогенни отговори
BG63182B2 (bg) Ваксиниране чрез специфични т- клетъчни популации срещу заболявания в резултат на патогенни отговори